|
⚲
|
| Commonwealth Bank of Australia | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0000008565 |
| Sale | 2010-02-04 ($30.0 B Offered, $1.4 B Sold) |
| Fund | |
| Phone | 61291181335 |
| Address | Ground Floor, Tower 1 Sydney Nsw, 2000 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Jane Hemstritch | |
| Ralph Norris | |
| David Craig | |
| David Turner | |
| Carolyn Kay | |
| David Cohen | |
| Colin Galbraith | |
| Reginald Clairs | |
| John Anderson | |
| Fergus Ryan | |
| Andrew Mohl | |
| Harrison Young |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Baylight Long Opportunity Fund, LP
✚
|
0.0 | |
|
Bayliss Patrick
✚
|
0.0 | |
|
Bay Management Co X, LLC
✚
|
0.0 | |
|
Bayou City Energy Affiliate Fund II, L.P.
✚
|
0.0 | |
|
Bayou City Energy II, L.P.
✚
|
0.0 | |
|
Bay Partners X Entrepreneurs Fund LP
✚
|
0.0 | |
|
Bay Partners X LP
✚
|
0.0 | |
|
Baztec Partners, LP
✚
|
0.0 | |
|
Bear Hill Road Second Avenue LLC
✚
|
0.0 | |
|
Bay City Capital GF Xinde International Life Sciences USD Fu
✚
|
0.0 |